On a chilly October morning in 1988, about 1,500 protesters descended upon a nondescript glass office building in suburban Rockville, Maryland. They were Aids patients, friends and queer activists from all over the country protesting what they saw as the failures of the US Food and Drug Administration to approve medications to fight Aids. The disease had already killed at last 45,000 Americans in less than a decade.
